Skip to main content

Table 4 The antifungal treatment prescribed to patients with hematologic malignancy and invasive mucormycosis

From: Characterizing patients with rare mucormycosis infections using real-world data

 

Overall HM cohort

N = 962,428

HM and IM cohort

N = 1133

n

%

n

%

Any antifungal treatment

119,414

12.41

382

33.72

Fluconazole

109,372

11.36

275

24.27

Voriconazole

9657

1.00

137

12.09

Micafungin

9443

0.98

72

6.35

Posaconazole

5080

0.53

185

16.33

Any amphotericin B

3521

0.37

177

15.62

Itraconazole

2685

0.28

24

2.12

Caspofungin

2635

0.27

56

4.94

Anidulafungin

1972

0.20

16

1.41

Isavuconazole

825

0.09

59

5.21

  1. HM hematologic malignancy, IM invasive mucormycosis, N the total number of patients, n number of patients in the category